Chinese University of Hong Kong: Cardiovascular Diseases trials

The registry lists 11 Cardiovascular Diseases studies with Chinese University of Hong Kong as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• AI-Based IMT StudyRecruitingNCT06768398
• Perceive and Calculated CV RiskRecruitingNCT05693857
• The Extension of HAPO Follow-up StudyRecruitingNCT05477511
• Time-trend Analysis of Clinical Characteristic and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Treated With PCI Over a 10-year PeriodActive, not recruitingNCT05548023Not applicable
• Health Coaching Programme on Health Promoting Behaviours in Middle-Aged Adults With Cardiometabolic RiskStatus unknownNCT05284162Not applicable
• The Hong Kong Diabetes BiobankActive, not recruitingNCT05282680
• Transversus Thoracis Muscle Plane Block for Sternotomy Pain in Cardiac SurgeryCompletedNCT04596163Not applicable
• Effectiveness of an E-health Educational Intervention for Cardiovascular Disease Adults in Improving OutcomesCompletedNCT02350192Not applicable
• The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body CompositionCompletedNCT00966615Phase 4
• Intravenous Pantoloc In Aspirin-Induced Ulcer BleedingCompletedNCT00153725Not applicable
• Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis PatientsCompletedNCT00153660Phase 3